5-Hydroxytryptamine-induced phosphoinositide hydrolysis and Ca2+ mobilisation in canine cultured aorta smooth muscle cells

Cellular Signalling

Volumn 11, Issue 5, 1999, Pages 361-370

  Chiu, Chi Tso ^a   Tsao, Hui Liang ^a   Fan, Lir Wan ^a   Wang, Chuan Chwan ^a   Chien, Chin Sung ^a   Yang, Chuen Mao ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

5 Hydroxytryptamine receptor; Aorta smooth muscle cells; Ca2+; Inositol phosphate; Pertussis toxin

Indexed keywords

CALCIUM; INOSITOL PHOSPHATE; NIFEDIPINE; PERTUSSIS TOXIN; SEROTONIN RECEPTOR; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; DOG; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

ANIMALS; AORTA; CALCIUM; CELLS, CULTURED; DOGS; FEMALE; HYDROLYSIS; INOSITOL PHOSPHATES; MALE; MUSCLE, SMOOTH, VASCULAR; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOLS; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; VIRULENCE FACTORS, BORDETELLA;

EID: 0032942103     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0898-6568(99)00010-8     Document Type: Article

References (42)

1. Apperley E., Feniuk W., Humphrey P. P. A. and Levy G. P. (1980) Br. J. Pharmacol. 68, 215-224.
2. Cohen M. L., Fuller R. W. and Wiley K. S. (1981) J. Pharmacol. Exp. Ther. 218, 421-425.
3. Frenken M. (1989) J. Pharmacol. Exp. Ther. 250, 379-387.
4. Parsons A. A., Whalley E. T., Feniuk W., Connor H. E. and Humphrey P. P. A. (1989) Br. J. Pharmacol. 96, 434-449.
5. Parsons A. A., Stutchbury C., Raval P. and Kaumann A. J. (1992) Naunyn-Schmiedeberg's Arch. Pharmacol. 346, 592-596.
6. Connor H. E., Feniuk W. and Humphrey P. P. A. (1989) Eur. J. Pharmacol. 161, 91-94
7. Humphrey P. P. A., Fenuik W., Perren M. J., Connor H. E., Oxford A. W., Coate I. H. and Butina D. (1988) Br. J. Pharmacol. 94, 1123-1132.
8. Ellwood A. J. and Curtis M. J. (1997) Br. J. Pharmacol. 122, 875-884.
9. Horowitz A., Menice C. B., Laporte R. and Morgan K. G. (1996) Physiol Rev. 76, 967-1003.
10. Somlyo A. and Somlyo A. V. (1994) Nature 372, 231-236.
11. Kendall D. A. and Nahorski S. R. (1985) J. Pharmacol. Exp. Ther. 233, 473-479.
12. Conn P. U., Sanders-Bush E., Hoffman B. J. and Harig P. R. (1986) Proc. Natl. Acad. Sci. USA 83, 4086-1088.
13. Kagaya A., Mikuni M., Muraoka S.-I., Saitoh K., Ogawa T., Shinno H., Yamawaki S. and Takahashi K. (1993) J. Neurochem. 61, 1050-1056.
14. Hamamori Y., Yokoyama M., Yamada M., Akita H., Goshima K. and Fukuzuki H. (1990) Circ. Res. 66, 1474-1483.
15. Yang C. M., Yo Y. L., Hsieh J. T. and Ong R. (1994) Br. J. Pharmacol. 111, 777-786.
16. Yang C. M., Hsieh J. T., Yo Y. L., Ong R. and Tsao H. L. (1994) Cell Calcium 16, 194-204.
17. Takuwa Y., Takuwa N. and Rasmussen H. (1987) Am. J. Physiol. 253, C817-C827.
18. Cauvin C. and van Breemen C. (1985) J. Cardiovasc. Pharmacol. 7, S4-S10.
19. Shieh C. C., Petrini M. F., Dwyer T. M. and Farley J. M. (1991) J. Pharmacol. Exp. Ther. 256, 141-148.
20. Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R. and Humphrey P. P. A. (1994) Pharmacol. Rev. 46, 157-203.
21. Maricq A. V., Peterson A. S., Brake A. J., Myers R. M. and Julius D. (1991) Science 254, 432-137.
22. Saxena P. R. and Villalon C. M. (1990) J. Cardiovasc. Pharmacol. 15(Suppl. 7), S17-S34.
23. Linas S. L., Marzec- Calvert R., Ullian M. E. and O'Brien R. F. (1988) Kidney Int. 34, 18-25.
24. Grynkiewicz G., Poenie M. and Tsien R. Y. (1985) J. Biol. Chem. 260, 3440-3450.
25. Furchgott R. F. (1972) In: Catecholamines: Handbook of Experimental Pharmacology, Vol. 33 (Blaschko H. and Muscholl E., Eds), pp. 283-335. Springer Verlag, Berlin, Heidelberg, New York.
26. Frazer A., Maayani S. and Wolfe B. B. (1990) Annu. Rev. Pharmacol. Toxicol. 30, 307-348.
27. Zifa E. and Fillion G. (1992) Pharmacol. Rev. 44, 401-458.
28. Baumgartner R. A., Wills-Karp M., Kaufman M. J., Munakata M. and Hirshman C. (1990) J. Pharmacol. Exp. Ther. 255, 165-173.
29. Buckner C. K., Dea D., Liberati N. and Krell R. D. (1991) J. Pharmacol. Exp. Ther. 257, 26-34.
30. Lemoine H. and Kaumann A. J.(986) Naunyn-Schmiedeberg's Arch. Pharmacol. 333, 91-97.
31. Watts S. W. and Cohen N. L. (1992) J. Pharmacol. Exp. Ther. 260, 1101-1106.
32. Chen L., McNeill J. R., Wilson T. W. and Gopalakrishnan V. (1995) Br. J. Pharmacol. 114, 1599-1604.
33. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K. and Masaki T. (1988) Nature 332, 411-415.
34. Roth B. L. and Chuang D.-M. (1987) Life Sci. 41, 1051-1064.
35. Garnovskaya M. N., Nebigil C. G., Arthur J. M., Spurney R. F. and Raymond J. R. (1995) Mol. Pharmacol. 48, 230-237.
36. Al-Hassani M. H., Garcia J. G. N. and Gunst S. J. (1993) Am. J. Physiol. 264, L53-L59.
37. Nelson M. T., Standen N. B., Brayden J. E. and Worly J. F. (1988) Nature 336, 382-385.
38. Berridge M. J. (1993) Nature 361, 315-325.
39. Eberhard D. A. and Holz R. W. (1991) Biochem. J. 279, 447-453.
40. Fisher S. K., Domask L. M. and Roland R. M. (1989) Mol. Pharmacol. 35, 195-204.
41. Bolton T. B. (1979) Physiol Rev. 59, 606-718.
42. van Breemen C. and Saida K. (1989) Annu. Rev. Physiol. 51, 315-329.